The first NOAC with
a reversal agent
a reversal agent
YOUR FORESIGHT.
HIS FUTURE.
Dabigatran etexilate (Pradaxa®) is proven to be safe and effective to lower the risk of stroke and gives you the assurance of reversibility with Idarucizumab (Praxbind®) in emergency situations.
Lower risk of major bleeding with Dabigatran vs Rivaroxaban from a real-world analysis
Document ID: PC-PH-104718
22/03/2023
Author: Boehringer Ingelheim
